Development of delayed-release proliposomes tablets for oral protein drug delivery

Drug Development and Industrial Pharmacy

Volumn 38, Issue 6, 2012, Pages 718-727

  Tantisripreecha, Charintra ^a   Jaturanpinyo, Montree ^a   Panyarachun, Busaba ^b   Sarisuta, Narong ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Bovine serum albumin; Delayed release tablets; Gastrointestinal stability; Liposomes; Proliposomes

Indexed keywords

BOVINE SERUM ALBUMIN; DRUG CARRIER; EUDRAGIT; LIPOSOME; PROLIPOSOME; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; DELAYED RELEASE FORMULATION; DRUG GRANULE; DRUG STABILITY; DRUG STRUCTURE; GRANULE CELL; STRUCTURE ANALYSIS; TABLET FORMULATION;

ADMINISTRATION, ORAL; ANIMALS; CATTLE; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; SERUM ALBUMIN, BOVINE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS;

EID: 84860376475     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.623168     Document Type: Article

References (37)

1. Pauletti GM, Gangwar S, Siahaan TJ, Aube J. (1997). Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies. Adv Drug Deliv Rev, 27:235-256. (Pubitemid 27417875)
2. Anderson KE, Stevenson BR, Rogers JA. (1999). Folic acid-PEOlabeled liposomes to improve gastrointestinal absorption of encapsulated agents. J Control Release, 60:189-198. (Pubitemid 29335945)
3. Chiang CM, Weiner N. (1987). Gastrointestinal uptake of liposomes II. In vivo studies. Int J Pharm, 40:143-150.
4. Guo J, Ping Q, Jiang G, Huang L, Tong Y. (2003). Chitosan-coated liposomes: Characterization and interaction with leuprolide. Int J Pharm, 260:167-173. (Pubitemid 36773915)
5. Iwanaga K, Ono S, Narioka K, Morimoto K, Kakemi M, Yamashita S, Nango M, Oku N. (1997). Oral delivery of insulin by using surface coating liposomes: Improvement of stability of insulin in GI tract. Int J Pharm, 157:73-80. (Pubitemid 27432583)
6. Sarmento B, Ferreira DC, Jorgensen L, van de Weert M. (2007). Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles. Eur J Pharm Biopharm, 65:10-17. (Pubitemid 44827699)
7. Song KH, Chung SJ, Shim CK. (2002). Preparation and evaluation of proliposomes containing salmon calcitonin. J Control Release, 84:27-37.
8. Ueno M. (1998). Liposomal heparin by the oral route. In: Gregoriadis G, (ed). Liposomes as Drug Carriers. New York: John Wiley & Son, pp. 609-619.
9. Witoonsaridsilp W, Panyarachun B, Sarisuta N, Müller-Goymann CC. (2010). Influence of microenvironment and liposomal formulation on secondary structure and bilayer interaction of lysozyme. Colloids Surf B Biointerfaces, 75:501-509.
10. Yamabe K, Kato Y, Onishi H, Machida Y. (2003). Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. J Control Release, 89:429-436. (Pubitemid 36555902)
11. van Winden ECA, Crommelin DJA. (1997). Long term stability of freeze-dried, lyoprotected doxorubicin liposomes. Eur J Pharm Biopharm, 43:295-307. (Pubitemid 28298788)
12. Barenholz Y, Crommelin DJA. (1994). Liposomes as pharmaceutical dosage forms. In: Boylan JC, (ed). Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker, pp. 1-39.
13. Payne NI, Timmins P, Ambrose CV, Ward MD, Ridgway F. (1986). Proliposomes: A novel solution to an old problem. J Pharm Sci, 75:325-329. (Pubitemid 16137097)
14. Hwang BY, Jung BH, Chung SJ, Lee MH, Shim,CK. (1997). In vitro skin permeation of nicotine from proliposomes. J Control Release, 49:177-184.
15. Ning MY, Guo YZ, Pan HZ, Yu HM, Gu ZW. (2005). Preparation and evaluation of proliposomes containing clotrimazole. Chem Pharm Bull, 53:620-624.
16. Yang ZJ, Hino T, Kawashima Y. (1993). Studies on the size of rehydrated new liposome from Scutellaria proliposomes. J Chin Pharm Univ, 24:161-164.
17. Chu MQ, Gu HC. (2002). The study on the preparation of tanshonones propoliposomes by the spray drying method. Chin Pharm J, 37:32-35.
18. Wei NN, Lu BI. (2003). Preparation, morphology and in vitro release of chitosan coated liposomes of fluorouracil for colon targeting. Acta Pharm Sinica, 38:53-56.
19. Hill M, Lapcík O, Hampl R. (1997). Evaluation and separation of steroid-bovine serum albumin conjugates by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl, 691:187-191. (Pubitemid 27168854)
20. ICH Q2B Guideline, (1996). Guideline on validation of analytical procedures: Methodology.
21. Dong A, Huang P, Caughey WS. (1990). Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry, 29:3303-3308. (Pubitemid 20131472)
22. Banerjee S, Li D. (1991). Interpreting multicomponent infrared spectra by derivative minimization. Appl Spectrosc, 45:1047-1049.
23. Fabian H, Schultz C, Naumann D, Landt O, Hahn U, Saenger W. (1993). Secondary structure and temperature-induced unfolding and refolding of ribonuclease T1 in aqueous solution. A Fourier transform infrared spectroscopic study. J Mol Biol, 232:967-981. (Pubitemid 23256985)
24. Gorga JC, Dong A, Manning MC, Woody RW, Caughey WS, Strominger JL. (1989). Histocompatibility complex antigens by Fourier transform infrared and circular dichroism: Comparison of the secondary structures of human class I and class II major spectroscopy. Proc Natl Acad Sci USA, 86, 2321-2325. (Pubitemid 19102500)
25. Griebenow K, Klibanov AM. (1996). On protein denaturation in aqueous-organic mixtures but not in pure organic solvents. J Am Chem Soc, 118:11695-11700. (Pubitemid 26417457)
26. Fang JY, Yu SY, Wu PC, Huang YB, Tsai YH. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm, 215:91-99.
27. Peters TJr. (1985). Serum albumin. Adv Protein Chem, 37:161-245.
28. Kragh-Hansen U. (1981). Molecular aspects of ligand binding to serum albumin. Pharmacol Rev, 33:17-53.
29. McLachlan AD, Walker JE. (1977). Evolution of serum albumin. J Mol Biol, 112:543-558. (Pubitemid 8121818)
30. Law SL, Lo WY, Lin M. (1994). Increase of liposome stability by incorporation of bovine serum albumin. Drug Dev Ind Pharm, 20:1411-1423. (Pubitemid 24201246)
31. Ermak TH, Giannasca PJ. (1998). Microparticle targeting to M cells. Adv Drug Deliv Rev, 34:261-283. (Pubitemid 28535115)
32. Miyazawa T, Shimanouchi T, Mizushima SI. (1956). Characteristic infrared bands of mono-substituted amides. J Chem Phys, 24:408-418.
33. Susi H. (1972). Infrared spectroscopy-conformation. Meth Enzymol, 26 PtC:455-472.
34. Susi H, Timasheff SN, Stevens L. (1967). Infrared spectra and protein conformations in aqueous solutions. I. The amide I band in H2O and D2O solutions. J Biol Chem, 242:5460-5466.
35. Timascheff F, Susi H, Stevens L. (1967). Infrared spectra and protein. J Biol Chem, 242:5467-5473.
36. Wang FYZ, Zhou Y, Wang S, Zhang L, Wu J. (2006). Influence of metal ions on phosphatidylcholine-bovine serum albumin model membrane, an FTIR study. J Mol Structure, 794:1-11. (Pubitemid 44176000)
37. Makarov MI, Haumaier L, Zech W. (2002). Nature of soil organic phosphorus: An assessment of peak assignments in the diester region of 31P NMR spectra. Soil Biol Biochem, 24:1467-1477. (Pubitemid 35180912)